Length of AdmissionNCT01723449
Predictors for Admission to Emergency Department More Than 48 Hours
An observational study of Length of Admission, run by University of Southern Denmark at 1 site in Denmark.
Trial summary
In Demark acutely admitted patients are supposed to stay in the Emergency Department (ED) bed ward if the anticipated duration of stay is less than 48 hours. However, it is not a trivial matter to estimate duration of stay for emergency patients. a number of factors affect this, eg. Read more about this study
- Who is it for?
- Ages 15 years and older
- Conditions the study is for
- Length of Admission
- How many people
- 730 participants
- Where
- 1 siteDenmark
- Study dates
- Nov 2012to Oct 2013
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: all admissions to Emergency department
Who may be able to join
- all patients admitted to the Emergency Department -
Who cannot join
- Children less than 15 years patients transferred from other hospitals
- -
Trial locations and contacts
1 site in 1 country.
About this study
In Demark acutely admitted patients are supposed to stay in the Emergency Department (ED) bed ward if the anticipated duration of stay is less than 48 hours.
However, it is not a trivial matter to estimate duration of stay for emergency patients. a number of factors affect this, eg. social background, disease, hospital organisation.
The aim of this study is to analyse whom are the best among the health staff to predict the length of stay: ED nurses, admitting doctors og the specialist, and to analyse if a number of variables can be used to improve the prediction.
- Conditions
- Length of Admission
What is being measured
The primary outcome is the main question the study is designed to answer.
length of admission in hours
participants will be followed for the duration of hospital stay, an expected average of 76 hours
Measured: admission to discharge
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Nov 2012 (estimated)
- Study startNov 2012
- Primary completionSep 2013
- Study completionOct 2013
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Length of AdmissionStudies of the same condition, open and under way.
- More trials run by University of Southern DenmarkThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 730 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Southern Denmark
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Christian Backer Mogensen, University of Southern Denmark
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01723449
- Sponsor's protocol ID
- SHS-ED-01-2012
- Status last verified
- Feb 2016
- First submitted
- 24 Oct 2012
- Last updated
- 17 Feb 2016
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Feb 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Predictors for Admission to Emergency Department More Than 48 Hours
- ClinicalTrials.gov ID
- NCT01723449
- Acronym / sponsor ID
- SHS-ED-01-2012
- Conditions
- Length of Admission
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 730 participants (actual)
- Lead sponsor
- University of Southern DenmarkUniversity, hospital or other
- Study start
- Nov 2012
- Primary completion
- Sep 2013 (actual)
- Study completion
- Oct 2013 (actual)
- First posted
- 7 Nov 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In Demark acutely admitted patients are supposed to stay in the Emergency Department (ED) bed ward if the anticipated duration of stay is less than 48 hours.
However, it is not a trivial matter to estimate duration of stay for emergency patients. a number of factors affect this, eg. social background, disease, hospital organisation.
The aim of this study is to analyse whom are the best among the health staff to predict the length of stay: ED nurses, admitting doctors og the specialist, and to analyse if a number of variables can be used to improve the prediction.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 15 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- all admissions to Emergency department
Key inclusion criteria (1 listed)
- all patients admitted to the Emergency Department -
Key exclusion criteria (2 listed)
- Children less than 15 years patients transferred from other hospitals
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
length of admission in hours
Time frame: admission to discharge
participants will be followed for the duration of hospital stay, an expected average of 76 hours
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Feb 2016.
Related trials for Length of Admission
Active, not recruitingObservational study
THE EFFECT OF CRP/LYMPHOCYTE AND NEUTROPHIL/LYMPHOCYTE RATIOS ON LENGTH OF HOSPITAL STAY AND MORTALITY IN PATIENTS ADMITTED TO THE BURN UNIT
Burn
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Length of Admission, run by University of Southern Denmark at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Feb 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
length of admission in hours (time frame: admission to discharge). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2016.